5-methoxyindole-2-carboxylic acid has been researched along with Apoplexy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forster, MJ; Li, R; Li, W; Liu, R; Ren, M; Simpkins, JW; Sumien, N; Thangthaeng, N; Wu, J; Yan, LJ; Yang, S | 1 |
Jin, Z; Wu, J; Yan, LJ; Yang, X | 1 |
2 other study(ies) available for 5-methoxyindole-2-carboxylic acid and Apoplexy
Article | Year |
---|---|
Administration of 5-methoxyindole-2-carboxylic acid that potentially targets mitochondrial dihydrolipoamide dehydrogenase confers cerebral preconditioning against ischemic stroke injury.
Topics: Adenosine Triphosphate; Administration, Oral; Animals; Brain; Brain Ischemia; Cell Death; Dihydrolipoamide Dehydrogenase; Disease Models, Animal; Gene Expression Regulation; Indoles; Ischemic Preconditioning; Male; Mitochondria; Mitochondrial Proteins; NAD(P)H Dehydrogenase (Quinone); Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Stroke | 2017 |
Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords neuroprotection against stroke injury by preserving mitochondrial function and attenuating oxidative stress.
Topics: Animals; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Male; Mitochondria; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Stroke; Treatment Outcome | 2018 |